A Japanese health ministry proposal to impose steeper price cuts on certain medicines deemed to carry poor cost-effectiveness profiles cleared…
HOME > REGULATORY
REGULATORY
- PAFSC’s Second Committee to Review Additional Indication for Afinitor on Oct. 31
October 19, 2012
- PAFSC Committee Recommends Approval for Switch OTC Version of Epadel 2 Years after Frist Review
October 18, 2012
- MHLW’s FY2013 Budget Request Seeks More Funding Aimed at Reducing the Drug Lag Based on Results of Policy Evaluation
October 18, 2012
- MHLW to Compile New Generic Share Goal, Roadmap within FY2012
October 17, 2012
- Generic Substitution Could Save 1.53 Trillion Yen in Healthcare Spending: MOF
October 17, 2012
- Former Health Minister Nagatsuma to Take Over as Chairman of Lower House Committee on Health, Labor and Welfare
October 17, 2012
- Mochida’s Epadel Hastily Added to Review List for PAFSC’s Committee on Non-Prescription Drugs
October 16, 2012
- Gov’t, Municipalities Aim to Conclude Discussions on Funding for 3 Add’l Vaccines by Year End
October 16, 2012
- PAFSC’s 1st Committee to Review 4 Products Including Pfizer’s Toviaz on Oct. 26
October 15, 2012
- MEXT Requests Budget for Boosting Number of Pharmacists, Promoting Generic Use at National University Hospitals
October 15, 2012
- Trilateral Meeting of Health Ministers to Be Postponed After China Cites Inability to Attend
October 15, 2012
- MHLW to Begin Pilot Study on Drug Risk Management Plans for Generics
October 12, 2012
- Discussions on Cost-Effective Assessments Are for Preserving National Health Insurance System: Parliamentary Secretary Umemura
October 11, 2012
- Results of Paper-Based Inspection of Japan’s Application for Membership in PIC/S to Be Reported Next May
October 10, 2012
- Dr Takenaka Tapped as NIBIO Advisor, Committed to Creation of Drug Discovery Network
October 9, 2012
- Senior Vice Minister of Health Sakurai Stresses Need to Rebuild Ties with JMA
October 9, 2012
- Health Minister Mitsui Hopes to Ban All Forms of Dispensing Point Services Including Those Using Credit Cards
October 9, 2012
- MHLW to Request Development of 5 Drugs/Indications Determined to Have Unmet Medical Needs
October 5, 2012
- Ministry-Wide Discussions on Generics Necessary: Parliamentary Secretary Umemura
October 4, 2012
- Senior Vice Minister Sakurai Calls for Industry-Growth Perspective on Long-Listed Drug Pricing
October 4, 2012
ページ
A Japanese drug pricing panel on November 11 discussed ways to respond to the US most-favored-nation (MFN) policy, with healthcare…
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…